FDA-2024-0041-V241

Type IB variation for application FDA-2024-0041. Type IB variation: Container Closure Change for Kcluximab — major revision

Variation Number
FDA-2024-0041-V241
Type
Type IB
Application
FDA-2024-0041
Change
CHG-2024-0241
Status
Failed
Fee
€1,340
Submitted
2023-04-17
Approved
—
Description

Type IB variation: Container Closure Change for Kcluximab — major revision